Epithelial Tumors, Malignant
6 clinical trials · Condition
◉ Watch Epithelial Tumors, Malignant
| Record | Firm | Date |
|---|---|---|
| Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors (NCT05141474) | Vall d'Hebron Institute of Oncology | 2021-10-28 |
| NHS-IL12 for Solid Tumors (NCT01417546) | National Cancer Institute (NCI) | 2011-12-12 |
| A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial Tumors (NCT01207323) | Genentech, Inc. | 2010-11-09 |
Track Epithelial Tumors, Malignant automatically
Every clearance here is in the API, with alerts when new ones post.